Trials / Completed
CompletedNCT00863707
A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
A Phase 4, Multicenter, Double-Blind, Randomized, Placebo-controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 511 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to assess the safety and tolerance of regadenoson in subjects with renal impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Regadenoson | IV |
| DRUG | Placebo | IV |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2009-03-18
- Last updated
- 2012-05-18
- Results posted
- 2011-01-31
Locations
41 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00863707. Inclusion in this directory is not an endorsement.